Sepsis: The Inflammatory Foundation of Pathophysiology and Therapy

References

• . Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007;35(8):1928–1936
   PubMed Web of Science ®Google Scholar
• . Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310
   PubMed Web of Science ®Google Scholar
• . Parrillo JE, Parker MM, Natanson C, . Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113(3):227–242
   PubMed Web of Science ®Google Scholar
• . Cronshaw HL, Daniels R, Bleetman A, Joynes E, Sheils M. Impact of the Surviving Sepsis Campaign on the recognition and management of severe sepsis in the emergency department: are we failing [published online ahead of print July 26, 2010]? Emerg Med J
   Google Scholar
• . Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554
   PubMed Web of Science ®Google Scholar
• . Andrews RM, Elixhauser A; Agency for Healthcare Research and Quality. The national hospital bill: growth trends and 2005 update on the most expensive conditions by payer. Healthcare Cost and Utilization Project. Statistical brief #42. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb42.pdf. December 2007. Accessed June 16, 2011
   Google Scholar
• . Kleinpell RM, Graves BT, Ackerman MH. Incidence, pathogenesis, and management of sepsis: an overview. AACN Adv Crit Care. 2006;17(4):385–393
   PubMedGoogle Scholar
• . Thomas L. Germs. N Engl J Med. 1972;287(11):553–555
   PubMed Web of Science ®Google Scholar
• . Meakins JL, Pietsch JB, Bubenick O, . Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg. 1977;186(3):241–250
   PubMed Web of Science ®Google Scholar
• . Lederer JA, Rodrick ML, Mannick JA. The effects of injury on the adaptive immune response. Shock. 1999;11(3):153–159
   PubMed Web of Science ®Google Scholar
• . Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 2001;16(2):83–96
   PubMed Web of Science ®Google Scholar
• . Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest. 2003;124(3):1103–1115
   PubMed Web of Science ®Google Scholar
• . Bone RC, Balk RA, Cerra FB, . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–1655
   PubMed Web of Science ®Google Scholar
• . Rivers E, Nguyen B, Havstad S, ; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377
   PubMed Web of Science ®Google Scholar
• . Otero RM, Nguyen HB, Huang DT, . Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest. 2006;130(5):1579–1595
   PubMed Web of Science ®Google Scholar
• . Levy MM, Fink MP, Marshall JC, ; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250–1256
   PubMed Web of Science ®Google Scholar
• . Donnino MW, Nguyen HB, Jacobsen G, Tomlanovich M, Rivers EP. Cryptic septic shock: a sub-analysis of early goal-directed therapy [abstract]. Chest. 2003;124(4):90S–b
   Web of Science ®Google Scholar
• . Nguyen HB, Rivers EP, Abrahamian FM, ; Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med. 2006;48(1):28–54
   PubMed Web of Science ®Google Scholar
• . Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420(6917):885–891
   PubMed Web of Science ®Google Scholar
• . Russell JA. Management of sepsis. N Engl J Med. 2006;355(16):1699–1713
   PubMed Web of Science ®Google Scholar
• . Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol. 2008;214(2):211–223
   PubMed Web of Science ®Google Scholar
• . Alves-Filho JC, Freitas A, Souto FO, . Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci USA. 2009;106(10):4018–4023
   PubMed Web of Science ®Google Scholar
• . Vermont CL, Hazelzet JA, de Kleijn ED, van den Dobbelsteen GP, de Groot R. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity. Crit Care. 2006;10(1):R33
   PubMed Web of Science ®Google Scholar
• . De Kock I, Van Daele C, Poelaert J. Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy. Acta Clin Belg. 2010;65(5):323–329
   PubMed Web of Science ®Google Scholar
• . Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA. 1994;271(3):226–233
   PubMed Web of Science ®Google Scholar
• . Remick DG. Pathophysiology of sepsis. Am J Pathol. 2007;170(5):1435–1444
   PubMed Web of Science ®Google Scholar
• . Ertel W, Kremer JP, Kenney J, . Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood. 1995;85(5):1341–1347
   PubMed Web of Science ®Google Scholar
• . Hotchkiss RS, Swanson PE, Freeman BD, . Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27(7):1230–1251
   PubMed Web of Science ®Google Scholar
• . Hotchkiss RS, Tinsley KW, Swanson PE, . Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ Tlymphocytes in humans. J Immunol. 2001;166(11):6952–6963
   PubMed Web of Science ®Google Scholar
• . Hotchkiss RS, Tinsley KW, Swanson PE, . Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol. 2002;168(5):2493–2500
   PubMed Web of Science ®Google Scholar
• . Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181(1):176–180
   PubMed Web of Science ®Google Scholar
• . Fukuzuka K, Edwards CK 3rd, Clare-Salzler M, Copeland EM 3rd, Moldawer LL, Mozingo DW. Glucocorticoid-induced, caspase-dependent organ apoptosis early after burn injury. Am J Physiol Regul Integr Comp Physiol. 2000;278(4):R1005–R1018
   PubMed Web of Science ®Google Scholar
• . Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138–150
   PubMed Web of Science ®Google Scholar
• . Brealey D, Brand M, Hargreaves I, . Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219–223
   PubMed Web of Science ®Google Scholar
• . Dellinger RP, Carlet JM, Masur H, ; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858–873
   PubMed Web of Science ®Google Scholar
• . Dellinger RP, Levy MM, Carlet JM, ; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296–327
   PubMed Web of Science ®Google Scholar
• . Vincent JL; International Sepsis Forum. Hemodynamic support in septic shock. Intensive Care Med. 2001;27( suppl 1):S80–S92
   PubMed Web of Science ®Google Scholar
• . Shapiro NI, Howell MD, Talmor D, . Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45(5):524–528
   PubMed Web of Science ®Google Scholar
• . Mikkelsen ME, Miltiades AN, Gaieski DF, . Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009;37(5):1670–1677
   PubMed Web of Science ®Google Scholar
• . Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32( 11 suppl):S513–S526
   PubMedGoogle Scholar
• . Jimenez MF, Marshall JC; International Sepsis Forum. Source control in the management of sepsis. Intensive Care Med. 2001;27( suppl 1):S49–S62
   PubMed Web of Science ®Google Scholar
• . Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130(5):797–810
   PubMed Web of Science ®Google Scholar
• . Newcomb D, Bolgos G, Green L, Remick DG. Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock. 1998;10(2):110–117
   PubMed Web of Science ®Google Scholar
• . Kumar A, Roberts D, Wood KE, . Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596
   PubMed Web of Science ®Google Scholar
• . Gaieski DF, Mikkelsen ME, Band RA, . Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010;38(4):1045–1053
   PubMed Web of Science ®Google Scholar
• . Kumar A, Haery C, Paladugu B, . The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis. 2006;193(2):251–258
   PubMed Web of Science ®Google Scholar
• . Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32( 11 suppl):S451–S454
   PubMedGoogle Scholar
• . Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134(1):172–178
   PubMed Web of Science ®Google Scholar
• . Hollenberg SM, Ahrens TS, Annane D, . Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32(9):1928–1948
   PubMed Web of Science ®Google Scholar
• . Rivers EP, Jaehne AK, Eichhorn-Wharry L, Brown S, Amponsah D. Fluid therapy in septic shock. Curr Opin Crit Care. 2010;16(4):297–308
   PubMed Web of Science ®Google Scholar
• . Rizoli SB. Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate. J Trauma. 2003;54( 5 suppl):S82–S88
   PubMedGoogle Scholar
• . Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med. 1999;27(1):200–210
   PubMed Web of Science ®Google Scholar
• . Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004;32( 11 suppl):S455–S465
   PubMedGoogle Scholar
• . De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med. 2003;31(6):1659–1667
   PubMed Web of Science ®Google Scholar
• . Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest. 1993;103(6):1826–1831
   PubMed Web of Science ®Google Scholar
• . Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med. 1996;24(9):1580–1590
   PubMed Web of Science ®Google Scholar
• . Russell JA, Walley KR, Singer J, ; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Eng J Med. 2008;358(9):877–887
   PubMed Web of Science ®Google Scholar
• . Hébert PC, Wells G, Blajchman MA, . A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409–417
   PubMed Web of Science ®Google Scholar
• . Vallet B, Robin E, Lebuffe G. Venous oxygen saturation as a physiologic transfusion trigger. Crit Care. 2010;14(2):213
   PubMed Web of Science ®Google Scholar
• . Sakr Y, Chierego M, Piagnerelli M, . Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med. 2007;35(7):1639–1644
   PubMed Web of Science ®Google Scholar
• . Vincent JL, Sakr Y, Sprung C, Harboe S, Damas P; Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators. Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology. 2008;108(1):31–39
   PubMed Web of Science ®Google Scholar
• . Hébert PC, Tinmouth A, Corwin HL. Controversies in RBC transfusion in the critically ill. Chest. 2007;131(5):1583–1590
   PubMed Web of Science ®Google Scholar
• . Gotloib L, Shostak A, Galdi P, Jaichenko J, Fudin R. Loss of microvascular negative charges accompanied by interstitial edema in septic rats' heart. Circ Shock. 1992;36(1):45–56
   PubMedGoogle Scholar
• . Wu LL, Liu MS. Heart sarcolemmal Ca2+ transport in endotoxin shock: I. Impairment of ATP-dependent Ca2+ transport. Mol Cell Biochem. 1992;112(2):125–133
   PubMed Web of Science ®Google Scholar
• . Rivers EP, Kruse JA, Jacobsen G, . The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med. 2007;35(9):2016–2024
   PubMed Web of Science ®Google Scholar
• . Cronin L, Cook DJ, Carlet J, . Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med. 1995;23(8):1430–1439
   PubMed Web of Science ®Google Scholar
• . Annane D, Sébille V, Charpentier C, . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862–871
   PubMed Web of Science ®Google Scholar
• . Sprung CL, Annane D, Keh D, ; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111–124
   PubMed Web of Science ®Google Scholar
• . Rivers EP, Blake HC, Dereczyk B, . Adrenal dysfunction in hemodynamically unstable patients in the emergency department. Acad Emerg Med. 1999;6(6):626–630
   PubMed Web of Science ®Google Scholar
• . Bernard GR, Vincent JL, Laterre PF, ; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344(10):699–709
   PubMed Web of Science ®Google Scholar
• . Nadel S, Goldstein B, Williams MD, ; REsearching severe Sepsis and Organ dysfunction in children: a gLobal perspective (RESOLVE) study group. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet. 2007;369(9564):863–843
   Web of Science ®Google Scholar
• . Martí-Carvajal AJ, Solà I, Lathyris D, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev. 2011;(4):CD004388
   Google Scholar
• . Kylat RI, Ohlsson A. Recombinant human activated protein C for severe sepsis in neonates. Cochrane Database Syst Rev. 2006;(2):CD005385
   Google Scholar
• . Silva E, de Figueiredo LF, Colombari F. Prowess-shock trial: a protocol overview and perspectives. Shock. 2010;34( suppl 1):48–53
   PubMed Web of Science ®Google Scholar
• . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301–1308
   PubMed Web of Science ®Google Scholar
• . Slutsky AS, Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med. 1998;157(6 pt 1):1721–1725
   PubMed Web of Science ®Google Scholar
• . Van den Berghe G, Wouters P, Weekers F, . Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–1367
   PubMed Web of Science ®Google Scholar
• . ; NICE-SUGAR Study InvestigatorsFinfer S, Chittock DR, Su SY, . Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–1297
   PubMed Web of Science ®Google Scholar
• . Hu Y, Xie GH, Chen QX, Fang XM. Small molecules in treatment of sepsis. Curr Drug Targets. 2011;12(2):256–262
   PubMed Web of Science ®Google Scholar
• . Ehrentraut S, Frede S, Stapel H, . Antagonism of lipopolysaccharide-induced blood pressure attenuation and vascular contractility. Arterioscler Thromb Vasc Biol. 2007;27(10):2170–2176
   PubMed Web of Science ®Google Scholar
• . Grogan K. Eisai pulls filings as sepsis drug fails phase III. Pharma Times Online Web site. http://www.pharmatimes.com/Article/11-01-26/Eisai_pulls_filings_as_sepsis_drug_fails_Phase_III.aspx. Published January 26, 2011. Accessed July 25, 2011
   Google Scholar